Cincinnati Children’s offers the broadest available platform of molecular and cellular diagnostic testing for thrombotic microangiopathies (TMA), including atypical hemolytic uremic syndrome (aHUS), thrombotic thrombocytopenia purpura (TTP) and transplantation-associated thrombotic microangiopathy (TA-TMA). Our diagnostic tests are easy to order and results are timely and clinically relevant.
Note: Effective August 1, 2017, our new requisition contains updated shipping information. Please update your records accordingly.
The Only Source for Comprehensive Testing
Cincinnati Children's is the only center in the United States that performs the full array of testing for thrombotic microangiopathies, streamlining a patient’s evaluation to a single institutional provider of these services.
Customized Test Results
Test results are summarized for each patient. Clinical information is incorporated with the genetic, biochemical and functional test results into a comprehensive report. The clinical significance of test results is explained, and recommendations are provided for additional testing, if warranted, as well as for clinical management.
Consultation with Recognized Clinical Experts
Cincinnati Children’s has board-certified pediatric nephrologists, hematologists, molecular geneticists and genetic counselors to provide telephone or email consultations to referring physicians regarding test selection, clinical interpretation, medical management and follow-up testing, genetic counseling, and additional studies of at-risk family members.